Cargando…
Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model
BACKGROUND: Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps required to get vaccines from their manufacturers to patients. The measles vaccine is particularly impor...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129313/ https://www.ncbi.nlm.nih.gov/pubmed/21635774 http://dx.doi.org/10.1186/1471-2458-11-425 |
_version_ | 1782207532222119936 |
---|---|
author | Assi, Tina-Marie Brown, Shawn T Djibo, Ali Norman, Bryan A Rajgopal, Jayant Welling, Joel S Chen, Sheng-I Bailey, Rachel R Kone, Souleymane Kenea, Hailu Connor, Diana L Wateska, Angela R Jana, Anirban Wisniewski, Stephen R Van Panhuis, Willem G Burke, Donald S Lee, Bruce Y |
author_facet | Assi, Tina-Marie Brown, Shawn T Djibo, Ali Norman, Bryan A Rajgopal, Jayant Welling, Joel S Chen, Sheng-I Bailey, Rachel R Kone, Souleymane Kenea, Hailu Connor, Diana L Wateska, Angela R Jana, Anirban Wisniewski, Stephen R Van Panhuis, Willem G Burke, Donald S Lee, Bruce Y |
author_sort | Assi, Tina-Marie |
collection | PubMed |
description | BACKGROUND: Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps required to get vaccines from their manufacturers to patients. The measles vaccine is particularly important in Niger, a country prone to measles outbreaks. METHODS: We developed a detailed discrete event simulation model of the vaccine supply chain representing every vaccine, storage location, refrigerator, freezer, and transport device (e.g., cold trucks, 4 × 4 trucks, and vaccine carriers) in the Niger Expanded Programme on Immunization (EPI). Experiments simulated the impact of replacing the 10-dose measles vial size with 5-dose, 2-dose and 1-dose vial sizes. RESULTS: Switching from the 10-dose to the 5-dose, 2-dose and 1-dose vial sizes decreased the average availability of EPI vaccines for arriving patients from 83% to 82%, 81% and 78%, respectively for a 100% target population size. The switches also changed transport vehicle's utilization from a mean of 58% (range: 4-164%) to means of 59% (range: 4-164%), 62% (range: 4-175%), and 67% (range: 5-192%), respectively, between the regional and district stores, and from a mean of 160% (range: 83-300%) to means of 161% (range: 82-322%), 175% (range: 78-344%), and 198% (range: 88-402%), respectively, between the district to integrated health centres (IHC). The switch also changed district level storage utilization from a mean of 65% to means of 64%, 66% and 68% (range for all scenarios: 3-100%). Finally, accounting for vaccine administration, wastage, and disposal, replacing the 10-dose vial with the 5 or 1-dose vials would increase the cost per immunized patient from $0.47US to $0.71US and $1.26US, respectively. CONCLUSIONS: The switch from the 10-dose measles vaccines to smaller vial sizes could overwhelm the capacities of many storage facilities and transport vehicles as well as increase the cost per vaccinated child. |
format | Online Article Text |
id | pubmed-3129313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31293132011-07-05 Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model Assi, Tina-Marie Brown, Shawn T Djibo, Ali Norman, Bryan A Rajgopal, Jayant Welling, Joel S Chen, Sheng-I Bailey, Rachel R Kone, Souleymane Kenea, Hailu Connor, Diana L Wateska, Angela R Jana, Anirban Wisniewski, Stephen R Van Panhuis, Willem G Burke, Donald S Lee, Bruce Y BMC Public Health Research Article BACKGROUND: Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps required to get vaccines from their manufacturers to patients. The measles vaccine is particularly important in Niger, a country prone to measles outbreaks. METHODS: We developed a detailed discrete event simulation model of the vaccine supply chain representing every vaccine, storage location, refrigerator, freezer, and transport device (e.g., cold trucks, 4 × 4 trucks, and vaccine carriers) in the Niger Expanded Programme on Immunization (EPI). Experiments simulated the impact of replacing the 10-dose measles vial size with 5-dose, 2-dose and 1-dose vial sizes. RESULTS: Switching from the 10-dose to the 5-dose, 2-dose and 1-dose vial sizes decreased the average availability of EPI vaccines for arriving patients from 83% to 82%, 81% and 78%, respectively for a 100% target population size. The switches also changed transport vehicle's utilization from a mean of 58% (range: 4-164%) to means of 59% (range: 4-164%), 62% (range: 4-175%), and 67% (range: 5-192%), respectively, between the regional and district stores, and from a mean of 160% (range: 83-300%) to means of 161% (range: 82-322%), 175% (range: 78-344%), and 198% (range: 88-402%), respectively, between the district to integrated health centres (IHC). The switch also changed district level storage utilization from a mean of 65% to means of 64%, 66% and 68% (range for all scenarios: 3-100%). Finally, accounting for vaccine administration, wastage, and disposal, replacing the 10-dose vial with the 5 or 1-dose vials would increase the cost per immunized patient from $0.47US to $0.71US and $1.26US, respectively. CONCLUSIONS: The switch from the 10-dose measles vaccines to smaller vial sizes could overwhelm the capacities of many storage facilities and transport vehicles as well as increase the cost per vaccinated child. BioMed Central 2011-06-02 /pmc/articles/PMC3129313/ /pubmed/21635774 http://dx.doi.org/10.1186/1471-2458-11-425 Text en Copyright ©2011 Assi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Assi, Tina-Marie Brown, Shawn T Djibo, Ali Norman, Bryan A Rajgopal, Jayant Welling, Joel S Chen, Sheng-I Bailey, Rachel R Kone, Souleymane Kenea, Hailu Connor, Diana L Wateska, Angela R Jana, Anirban Wisniewski, Stephen R Van Panhuis, Willem G Burke, Donald S Lee, Bruce Y Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model |
title | Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model |
title_full | Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model |
title_fullStr | Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model |
title_full_unstemmed | Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model |
title_short | Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model |
title_sort | impact of changing the measles vaccine vial size on niger's vaccine supply chain: a computational model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129313/ https://www.ncbi.nlm.nih.gov/pubmed/21635774 http://dx.doi.org/10.1186/1471-2458-11-425 |
work_keys_str_mv | AT assitinamarie impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT brownshawnt impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT djiboali impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT normanbryana impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT rajgopaljayant impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT wellingjoels impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT chenshengi impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT baileyrachelr impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT konesouleymane impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT keneahailu impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT connordianal impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT wateskaangelar impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT janaanirban impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT wisniewskistephenr impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT vanpanhuiswillemg impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT burkedonalds impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel AT leebrucey impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel |